What changed: Chordoma
Every dated change on the records linked to Chordoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Guideline1Milestone7This record1
September 2026 · 1
2021 · 1
2020 · 1
2015 · 2
- 2015GuidelineChordomaGuideline NCCN Guidelines: Bone Cancer; Chordoma Global Consensus Group (Lancet Oncol 2015): Resectable, any site
En bloc resection with negative margins by a spine or skull-base team, followed by high-dose proton or carbon-ion radiotherapy; intralesional surgery is associated with early recurrence. (NCCN Category 2A)
- 2015MilestoneChordomaChordoma Global Consensus Group
First international recommendations on surgery, radiotherapy and systemic therapy (Lancet Oncol).